Keratin 17 testing in pancreatic cancer needle aspiration biopsies predicts survival.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer cytopathology"
DOI: 10.1002/cncy.22438
Abstract: BACKGROUND Although pancreatic ductal adenocarcinoma (PDAC) has one of the lowest 5-year survival rates of all cancers, differences in survival exist between patients with clinically identical characteristics. The authors previously demonstrated that keratin 17 (K17)… read more here.
Keywords: k17; needle aspiration; k17 ihc; expression ... See more keywords
Abstract B50: Keratin 17 drives tumor aggression and could be targeted for treatment of pancreatic ductal adenocarcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Research"
DOI: 10.1158/1538-7445.panca19-b50
Abstract: Our aims are to uncover the molecular mechanisms through which keratin 17 (K17), a prognostic biomarker, drives tumor aggression and to target these mechanisms to provide more effective treatment for pancreatic ductal adenocarcinoma (PDAC). In… read more here.
Keywords: k17; drives tumor; treatment; tumor aggression ... See more keywords
Keratin 17 is an imaging biomarker in lung cancers.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2019.08.33
Abstract: Background Computed tomographic (CT) features have demonstrated their value in classifying and assessing pulmonary nodules. Additionally, recent studies have shown the presence of keratin 17 (K17) in lung cancer is associated with increased mortality compared… read more here.
Keywords: presence; lung; k17; lung cancer ... See more keywords